Infant CD4 T-Cell Response to SARS-CoV-2 mRNA Vaccination Is Restricted in Cytokine Production and Modified by Vaccine Manufacturer - Summary - MDSpire
Advertisement
Infant CD4 T-Cell Response to SARS-CoV-2 mRNA Vaccination Is Restricted in Cytokine Production and Modified by Vaccine Manufacturer
To characterize the CD4 T-cell response to SARS-CoV-2 mRNA vaccination in infants and compare it specifically with adult responses.
Key Findings:
Infants showed a significant increase in CD4 T-cells producing IL-2 and TNF-α post-vaccination, but a muted induction of IFN-γ.
In contrast, adults exhibited robust production of all three cytokines (IL-2, TNF-α, IFN-γ) following vaccination.
CD4 T-cell responses were greater in infants receiving mRNA-1273 compared to BNT162b.
Spike-specific IgG titers were similar in infants and adults.
Interpretation:
Infants have a restricted induction of cytokine-producing CD4 T-cells following SARS-CoV-2 mRNA vaccination compared to adults, indicating potential differences in immune response quality that may affect infant immunity.
Limitations:
Small sample size of infants (n=13) may limit generalizability and the robustness of conclusions drawn.
Limited historical data on T-cell responses in infants compared to adults.
Conclusion:
The study highlights the differences in CD4 T-cell responses between infants and adults following SARS-CoV-2 mRNA vaccination, suggesting a need for further research to understand the implications for infant immunity and potential strategies to enhance their immune response.
by M Quinn Peters, Amber L Young, Jennifer E Stolarczuk, Madeline Glad, Erik Layton, Jennifer K Logue, Nana K Minkah, Helen Y Chu, Janet A Englund, D Noah Sather, Chetan Seshadri, Alisa Kachikis, Whitney E Harrington
